29.10.2004   

LT

Europos Sąjungos oficialusis leidinys

C 266/5


Bendrijos sprendimų dėl leidimų prekiauti vaistais sąrašas nuo 2004 m. rugsėjo 15 d. iki 2004 m. spalio 15 d.

(paskelbta sutinkamai su Tarybos Reglamento (EEB) Nr. 2309/93 (1) 12 arba 34 straipsniu)

(2004/C 266/04)

Leidimo prekiauti išdavimas (Tarybos Reglamento (EEB) Nr. 2309/93 12 straipsnis), leidimas išduotas

Sprendimo data

Vaisto pavadinimas

Leidimo savininkas

Įrašo Bendrijos registre nr.

Pranešimo data

2004 9 20

Angiox

The Medicines Company UK Ltd, Suite B, Park House, 11 Milton Park, Abingdon, Oxfordshire OX14 4RS, United Kingdom

EU/1/04/289/001

2004 9 22

2004 9 20

Alimta

Eli Lilly Nederland B.V., Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/04/290/001

2004 9 22

2004 9 20

Raptiva

Serono Europe Limited, 56, Marsh Wall, London E14 9TP, United Kingdom

EU/1/04/291/001-002

2004 9 22

2004 9 21

Protelos

Les Laboratoires Servier, 22, rue Garnier, F-92200 Neuilly sur-Seine, France.

EU/1/04/288/001-006

2004 9 23

2004 9 21

Osseor

Les Laboratoires Servier, 22, rue Garnier, F-92200 Neuilly sur-Seine, France

EU/1/04/287/001-006

2004 9 23

2004 9 27

Apidra

Aventis Pharma Deutschland GmbH, Brueningstrasse 50, D-65926 Frankfurt am Main, Deutschland

EU/1/04/285/001-020

2004 9 29

2004 10 13

Wilzin

Orphan Europe SARL, Immeuble „Le Guillaumet“F-92046 Paris-La-Défense - France

EU/1/04/286/001-002

2004 10 18

Leidimo prekiauti pakeitimas (Tarybos Reglamento (EEB) Nr. 2309/93 12 straipsnis), leidimas pakeistas

Sprendimo data

Vaisto pavadinimas

Leidimo savininkas

Įrašo Bendrijos registre nr.

Pranešimo data

2004 9 20

Remicade

Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland

EU/1/99/116/001-003

2004 9 22

2004 9 20

Azomyr

Schering Plough Europe, Rue de Stalle 73, B-1180 Bruxelles, Belgique

EU/1/00/157/014-021

2004 9 22

2004 9 20

Aerius

Schering Plough Europe, Rue de Stalle 73, B-1180 Bruxelles, Belgique

EU/1/00/160/014-021

2004 9 22

2004 9 20

Neoclarityn

Schering Plough Europe, Rue de Stalle 73, B-1180 Bruxelles, Belgique

EU/1/00/161/014-021

2004 9 22

2004 9 20

Lantus

Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main, Deutschland

EU/1/00/134/008-011

EU/1/00/134/018-021

2004 9 22

2004 9 20

Velcade

Millennium Pharmaceuticals, Ltd, Building 3, Chiswick Park, 566 Chiswick High Road, Chiswick, London, W4 5YA United Kingdom

EU/1/04/274/001

2004 9 22

2004 9 20

Velcade

Janssen-Cilag International NV, Turnhoutsewe 30, B-2340 Beerse, België

EU/1/04/274/001

2004 9 23

2004 9 20

Ovitrelle

Serono Europe Limited, 56, Marsh Wall, London E14 9TP, United Kingdom

EU/1/00/165/001-007

2004 9 22

2004 9 21

Carbaglu

Orphan Europe, Immeuble „Le Guillaumet“, F-92046 Paris La Défense, France

EU/1/02/246/001-002

2004 9 23

2004 9 21

KOGENATE Bayer

Bayer AG, D-51368 Leverkusen, Deutschland

EU/1/00/143/004-006

2004 9 23

2004 9 23

Remicade

Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland

EU/1/99/116/001-003

2004 9 27

2004 9 24

Insuman

Aventis Pharma Deutschland GmbH, Brueningstrasse 50, D-65926 Frankfurt am Main, Deutschland

EU/1/97/030/065-084

2004 9 29

2004 9 24

InductOs

Wyeth Europa Ltd., Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom

EU/1/02/226/001

2004 9 28

2004 9 24

Enbrel

Wyeth Europa Limited, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom

EU/1/99/126/001-003

2004 9 28

2004 9 27

SonoVue

Bracco International B.V., Strawinskylaan 3051, 1077ZX Amsterdam, Nederland

EU/1/01/177/001-002

2004 9 29

2004 9 27

Ceprotin

Baxter AG, Industriesstrasse 67, A-1220 Vienna, Österreich

EU/1/01/190/001-002

2004 9 29

2004 9 27

Avonex

Biogen Idec France, „Le Capitole“ 55, avenue des Champs Pierreux, F-92012 Nanterre Cedex - France.

EU/1/97/033/001-003

2004 9 30

2004 10 13

Revasc

Canyon Pharmaceuticals Ltd, 20-22 Bedford Row - WC1R 4JS London - United Kingdom

EU/1/97/043/001-002

2004 10 19

Aventis Pharma S.A., 20 Avenue Raymond Aron, Antony Cedex F-92165, France

2004 10 18

2004 10 13

Arava

Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main, Deutschland

EU/1/99/118/001-010

2004 10 18

2004 10 13

Vaniqa

Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, United Kingdom

EU/1/01/173/001-003

2004 10 18

2004 10 13

NovoRapid

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/99/119/001-014

2004 10 18

2004 10 13

Levviax

Aventis Pharma S.A., 20 Avenue Raymond Aron, F-92160 Antony, France

EU/1/01/192/001-005

2004 10 19

2004 10 15

Ketek

Aventis Pharma S.A., 20 Avenue Raymond Aron, F-92160 Antony, France

EU/1/01/191/001-005

2004 10 19

2004 10 15

Viramune

Boehringer Ingelheim International GmbH, Binger Strasse 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/97/055/001-002

2004 10 19

2004 10 15

Fuzeon

Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom

EU/1/03/252/001-003

2004 10 20

2004 10 15

NovoRapid

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/99/119/001

EU/1/99/119/003

EU/1/99/119/005-014

2004 10 19

Leidimo prekiauti panaikinimas (Tarybos Reglamento (EEB) Nr. 2309/93 12 straipsnis)

Sprendimo data

Vaisto pavadinimas

Leidimo savininkas

Įrašo Bendrijos registre nr.

Pranešimo data

2004 9 28

Ixense

Takeda Europe R&D Centre Ltd, Savanah House, 11/12 Charles II Street, London SW1Y 4QU, United Kingdom

EU/1/01/181/001-007

2004 9 30


(1)  OL L 214, 1993 8 24, p. 1.